Susquehanna International Group
WVE icon

Susquehanna International Group’s Wave Life Sciences WVE Stock Holding History

Susquehanna International Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.62M Sell
499,200
-286,500
-36% -$3.73M ﹤0.01% 4872
2025
Q4 		$13.4M Buy
785,700
+675,600
+614% +$6.86M ﹤0.01% 2686
2025
Q3 		$806K Buy
110,100
+91,700
+498% +$742K ﹤0.01% 7854
2025
Q2 		$120K Sell
18,400
-336,400
-95% -$2.22M ﹤0.01% 11676
2025
Q1 		$2.87M Buy
354,800
+110,300
+45% +$1.21M ﹤0.01% 4740
2024
Q4 		$3.02M Buy
244,500
+156,500
+178% +$2.09M ﹤0.01% 4466
2024
Q3 		$722K Buy
88,000
+69,200
+368% +$414K ﹤0.01% 7576
2024
Q2 		$93.8K Sell
18,800
-39,300
-68% -$224K ﹤0.01% 11064
2024
Q1 		$358K Sell
58,100
-9,700
-14% -$48.6K ﹤0.01% 9284
2023
Q4 		$342K Buy
67,800
+29,300
+76% +$157K ﹤0.01% 9546
2023
Q3 		$221K Buy
38,500
+21,300
+124% +$97.2K ﹤0.01% 10016
2023
Q2 		$62.6K Sell
17,200
-28,100
-62% -$113K ﹤0.01% 11231
2023
Q1 		$196K Sell
45,300
-69,100
-60% -$317K ﹤0.01% 10618
2022
Q4 		$801K Buy
114,400
+89,500
+359% +$412K ﹤0.01% 6667
2022
Q3 		$90K Buy
24,900
+9,300
+60% +$30.8K ﹤0.01% 11790
2022
Q2 		$51K Buy
15,600
+5,000
+47% +$9.62K ﹤0.01% 11966
2022
Q1 		$21K Sell
10,600
-2,300
-18% -$5.63K ﹤0.01% 12610
2021
Q4 		$41K Sell
12,900
-26,600
-67% -$110K ﹤0.01% 12651
2021
Q3 		$194K Buy
39,500
+5,500
+16% +$33.3K ﹤0.01% 11518
2021
Q2 		$226K Sell
34,000
-261,700
-89% -$1.71M ﹤0.01% 11328
2021
Q1 		$1.66M Buy
295,700
+279,000
+1,671% +$2.68M ﹤0.01% 6375
2020
Q4 		$131K Sell
16,700
-49,100
-75% -$412K ﹤0.01% 10345
2020
Q3 		$559K Buy
65,800
+39,500
+150% +$433K ﹤0.01% 7440
2020
Q2 		$274K Buy
26,300
+12,200
+87% +$115K ﹤0.01% 8506
2020
Q1 		$132K Sell
14,100
-118,100
-89% -$1.01M ﹤0.01% 9108
2019
Q4 		$1.06M Buy
132,200
+116,300
+731% +$2.85M ﹤0.01% 5411
2019
Q3 		$326K Sell
15,900
-6,100
-28% -$140K ﹤0.01% 8123
2019
Q2 		$574K Sell
22,000
-16,400
-43% -$460K ﹤0.01% 6993
2019
Q1 		$1.49M Buy
+38,400
New +$1.56M ﹤0.01% 4248

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Susquehanna International Group's WVE Position: Q1 2026 in Review

Susquehanna International Group reduced its Wave Life Sciences (WVE) stake by 31% in Q1 2026, selling an estimated $1.55M and leaving 259,825 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #6318.

Susquehanna International Group first reported a position in WVE in Q1 2016 and has held it in 25 quarters since. The position peaked at $6.44M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Susquehanna International Group held 259,825 shares of Wave Life Sciences worth $1.88M as of Q1 2026.
  • Susquehanna International Group sold 119,162 Wave Life Sciences shares in Q1 2026, an estimated $1.55M.
  • Wave Life Sciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6318 holding.
  • Susquehanna International Group first reported a position in Wave Life Sciences in Q1 2016 and has held it in 25 quarters since.
  • Susquehanna International Group's Wave Life Sciences position peaked at $6.44M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.